• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
New chemical tools for probing activity and inhibition of the NAD-dependent lysine deacylase sirtuin 2.用于探测 NAD 依赖性赖氨酸去酰化酶 Sirtuin 2 的活性和抑制作用的新化学工具。
Philos Trans R Soc Lond B Biol Sci. 2018 Jun 5;373(1748). doi: 10.1098/rstb.2017.0083.
2
Structure-Based Development of an Affinity Probe for Sirtuin 2.基于结构的 Sirtuin 2 亲和探针的开发。
Angew Chem Int Ed Engl. 2016 Feb 5;55(6):2252-6. doi: 10.1002/anie.201509843. Epub 2016 Jan 8.
3
Identification of a novel small molecule that inhibits deacetylase but not defatty-acylase reaction catalysed by SIRT2.鉴定一种新型小分子,该小分子抑制去乙酰化酶,但不抑制 SIRT2 催化的脱脂酰基酶反应。
Philos Trans R Soc Lond B Biol Sci. 2018 Jun 5;373(1748). doi: 10.1098/rstb.2017.0070.
4
Investigating the Sensitivity of NAD+-dependent Sirtuin Deacylation Activities to NADH.研究烟酰胺腺嘌呤二核苷酸(NAD⁺)依赖性去乙酰化酶活性对还原型烟酰胺腺嘌呤二核苷酸(NADH)的敏感性。
J Biol Chem. 2016 Mar 25;291(13):7128-41. doi: 10.1074/jbc.M115.668699. Epub 2016 Feb 9.
5
Opening the Selectivity Pocket in the Human Lysine Deacetylase Sirtuin2 - New Opportunities, New Questions.打开人类赖氨酸去乙酰化酶 Sirtuin2 的选择性口袋——新机遇,新问题。
Chem Rec. 2018 Dec;18(12):1701-1707. doi: 10.1002/tcr.201800044. Epub 2018 Jun 21.
6
Molecular modeling study for conformational changes of Sirtuin 2 due to substrate and inhibitor binding.基于配体结合的 Sirtuin 2 构象变化的分子建模研究。
J Biomol Struct Dyn. 2012;30(3):235-54. doi: 10.1080/07391102.2012.680026. Epub 2012 Jun 12.
7
Aminothiazoles as Potent and Selective Sirt2 Inhibitors: A Structure-Activity Relationship Study.作为强效和选择性Sirt2抑制剂的氨基噻唑:构效关系研究
J Med Chem. 2016 Feb 25;59(4):1599-612. doi: 10.1021/acs.jmedchem.5b01517. Epub 2016 Jan 7.
8
Kinetic and Structural Basis for Acyl-Group Selectivity and NAD(+) Dependence in Sirtuin-Catalyzed Deacylation.沉默调节蛋白催化脱酰基反应中酰基选择性和NAD⁺依赖性的动力学及结构基础
Biochemistry. 2015 May 19;54(19):3037-3050. doi: 10.1021/acs.biochem.5b00150. Epub 2015 May 4.
9
Seeding for sirtuins: microseed matrix seeding to obtain crystals of human Sirt3 and Sirt2 suitable for soaking.沉默调节蛋白的晶种筛选:采用微种子矩阵法筛选晶种以获得适合浸泡的人源Sirt3和Sirt2晶体。
Acta Crystallogr F Struct Biol Commun. 2015 Dec;71(Pt 12):1498-510. doi: 10.1107/S2053230X15019986. Epub 2015 Nov 18.
10
Fluorescence-based screening assays for the NAD⁺-dependent histone deacetylase smSirt2 from Schistosoma mansoni.基于荧光的曼氏血吸虫NAD⁺依赖性组蛋白去乙酰化酶smSirt2的筛选测定法。
J Biomol Screen. 2015 Jan;20(1):112-21. doi: 10.1177/1087057114555307. Epub 2014 Oct 16.

引用本文的文献

1
Efficient Crystallization of Apo Sirt2 for Small-Molecule Soaking and Structural Analysis of Ligand Interactions.无辅基Sirt2的高效结晶用于小分子浸泡及配体相互作用的结构分析
J Med Chem. 2025 Jun 12;68(11):10771-10780. doi: 10.1021/acs.jmedchem.4c02896. Epub 2025 May 20.
2
Fragment Screening Reveals Novel Scaffolds against Sirtuin-2-Related Protein 1 from .片段筛选揭示了针对来自……的与沉默调节蛋白2相关蛋白1的新型骨架。
ACS Omega. 2024 Dec 27;10(4):3808-3819. doi: 10.1021/acsomega.4c09231. eCollection 2025 Feb 4.
3
Activation and inhibition of sirtuins: From bench to bedside.沉默调节蛋白的激活与抑制:从实验室到临床应用
Med Res Rev. 2025 Mar;45(2):484-560. doi: 10.1002/med.22076. Epub 2024 Aug 31.
4
A homogeneous time-resolved fluorescence screen to identify SIRT2 deacetylase and defatty-acylase inhibitors.一种均相时间分辨荧光屏,用于鉴定 SIRT2 脱乙酰酶和脱脂酶抑制剂。
PLoS One. 2024 Jun 24;19(6):e0305000. doi: 10.1371/journal.pone.0305000. eCollection 2024.
5
Development of First-in-Class Dual Sirt2/HDAC6 Inhibitors as Molecular Tools for Dual Inhibition of Tubulin Deacetylation.开发首创的 Sirt2/HDAC6 双重抑制剂作为双重抑制微管去乙酰化的分子工具。
J Med Chem. 2023 Nov 9;66(21):14787-14814. doi: 10.1021/acs.jmedchem.3c01385. Epub 2023 Oct 30.
6
SIRT2-KLF4 Interactions are Critical for Myeloma Survival and Migration.SIRT2-KLF4 相互作用对骨髓瘤的存活和迁移至关重要。
Comput Intell Neurosci. 2022 May 27;2022:7356477. doi: 10.1155/2022/7356477. eCollection 2022.
7
Sirtuin modulators: past, present, and future perspectives.Sirtuin 调节剂:过去、现在和未来的展望。
Future Med Chem. 2022 Jun;14(12):915-939. doi: 10.4155/fmc-2022-0031. Epub 2022 May 18.
8
Structure-based design, synthesis, and biological evaluation of novel piperine-resveratrol hybrids as antiproliferative agents targeting SIRT-2.基于结构的新型胡椒碱-白藜芦醇杂合物作为靶向SIRT-2的抗增殖剂的设计、合成及生物学评价
RSC Adv. 2021 Jul 27;11(41):25738-25751. doi: 10.1039/d1ra04061h. eCollection 2021 Jul 19.
9
Development of a NanoBRET assay to validate inhibitors of Sirt2-mediated lysine deacetylation and defatty-acylation that block prostate cancer cell migration.开发一种纳米生物发光共振能量转移(NanoBRET)检测方法,以验证抑制Sirt2介导的赖氨酸去乙酰化和去脂肪酰化从而阻断前列腺癌细胞迁移的抑制剂。
RSC Chem Biol. 2022 Mar 1;3(4):468-485. doi: 10.1039/d1cb00244a. eCollection 2022 Apr 6.
10
Correlation Analysis of Protein Expression of 10 HDAC/Sirtuin Isoenzymes with Sensitivities of 23 Anticancer Drugs in 17 Cancer Cell Lines and Potentiation of Drug Activity by Co-Treatment with HDAC Inhibitors.17种癌细胞系中10种组蛋白去乙酰化酶/沉默调节蛋白同工酶的蛋白表达与23种抗癌药物敏感性的相关性分析以及组蛋白去乙酰化酶抑制剂联合治疗对药物活性的增强作用
Cancers (Basel). 2021 Dec 31;14(1):187. doi: 10.3390/cancers14010187.

本文引用的文献

1
Sirtuin 2 Regulates Microvascular Inflammation during Sepsis.Sirtuin 2 调节脓毒症期间的微血管炎症。
J Immunol Res. 2017;2017:2648946. doi: 10.1155/2017/2648946. Epub 2017 Apr 19.
2
Chemically Induced Degradation of Sirtuin 2 (Sirt2) by a Proteolysis Targeting Chimera (PROTAC) Based on Sirtuin Rearranging Ligands (SirReals).基于 Sirtuin 重排配体(SirReals)的蛋白水解靶向嵌合体(PROTAC)诱导 Sirtuin 2(Sirt2)化学降解。
J Med Chem. 2018 Jan 25;61(2):482-491. doi: 10.1021/acs.jmedchem.6b01872. Epub 2017 Apr 17.
3
Discovery of New SIRT2 Inhibitors by Utilizing a Consensus Docking/Scoring Strategy and Structure-Activity Relationship Analysis.利用共识对接/评分策略和构效关系分析发现新型 SIRT2 抑制剂。
J Chem Inf Model. 2017 Apr 24;57(4):669-679. doi: 10.1021/acs.jcim.6b00714. Epub 2017 Mar 28.
4
The mechanism of sirtuin 2-mediated exacerbation of alpha-synuclein toxicity in models of Parkinson disease.在帕金森病模型中,沉默调节蛋白2介导α-突触核蛋白毒性加剧的机制。
PLoS Biol. 2017 Mar 3;15(3):e2000374. doi: 10.1371/journal.pbio.2000374. eCollection 2017 Mar.
5
Thienopyrimidinone Based Sirtuin-2 (SIRT2)-Selective Inhibitors Bind in the Ligand Induced Selectivity Pocket.基于噻吩并嘧啶酮的Sirtuin-2(SIRT2)选择性抑制剂结合于配体诱导的选择性口袋中。
J Med Chem. 2017 Mar 9;60(5):1928-1945. doi: 10.1021/acs.jmedchem.6b01690. Epub 2017 Feb 15.
6
The Current State of NAD -Dependent Histone Deacetylases (Sirtuins) as Novel Therapeutic Targets.NAD+-依赖性组蛋白去乙酰化酶(Sirtuins)作为新型治疗靶点的现状。
Med Res Rev. 2018 Jan;38(1):147-200. doi: 10.1002/med.21436. Epub 2017 Jan 17.
7
SIRT7 Is an RNA-Activated Protein Lysine Deacylase.SIRT7是一种RNA激活的蛋白质赖氨酸脱酰酶。
ACS Chem Biol. 2017 Jan 20;12(1):300-310. doi: 10.1021/acschembio.6b00954. Epub 2016 Dec 20.
8
SIRT7 Is Activated by DNA and Deacetylates Histone H3 in the Chromatin Context.SIRT7 被 DNA 激活并在染色质环境中使组蛋白 H3 去乙酰化。
ACS Chem Biol. 2016 Mar 18;11(3):742-7. doi: 10.1021/acschembio.5b01084. Epub 2016 Mar 3.
9
An improved fluorogenic assay for SIRT1, SIRT2, and SIRT3.一种针对SIRT1、SIRT2和SIRT3的改进型荧光检测法。
Org Biomol Chem. 2016 Feb 21;14(7):2186-90. doi: 10.1039/c5ob02609a. Epub 2016 Jan 21.
10
A Continuous, Fluorogenic Sirtuin 2 Deacylase Assay: Substrate Screening and Inhibitor Evaluation.一种连续的、荧光性的沉默调节蛋白2去乙酰化酶检测方法:底物筛选与抑制剂评估。
J Med Chem. 2016 Feb 11;59(3):1021-31. doi: 10.1021/acs.jmedchem.5b01532. Epub 2016 Jan 20.

用于探测 NAD 依赖性赖氨酸去酰化酶 Sirtuin 2 的活性和抑制作用的新化学工具。

New chemical tools for probing activity and inhibition of the NAD-dependent lysine deacylase sirtuin 2.

机构信息

Institute of Pharmaceutical Sciences, University of Freiburg, Albertstraße 19, 79104 Freiburg im Breisgau, Germany.

Department of Chemistry, Chemistry Research Laboratory, University of Oxford, Mansfield Road, Oxford OX1 3TA, UK.

出版信息

Philos Trans R Soc Lond B Biol Sci. 2018 Jun 5;373(1748). doi: 10.1098/rstb.2017.0083.

DOI:10.1098/rstb.2017.0083
PMID:29685963
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5915722/
Abstract

Sirtuins are NAD-dependent protein deacylases capable of cleaving off acetyl as well as other acyl groups from the ɛ-amino group of lysines in histones and other substrate proteins. They have been reported as promising drug targets, and thus modulators of their activity are needed as molecular tools to uncover their biological function and as potential therapeutics. Here, we present new assay formats that complement existing assays for sirtuin biochemistry and cellular target engagement. Firstly, we report the development of a homogeneous fluorescence-based activity assay using unlabelled acylated peptides. Upon deacylation, the free lysine residue reacts with fluorescamine to form a fluorophore. Secondly, using click chemistry with a TAMRA-azide on a propargylated sirtuin inhibitor, we prepared the first fluorescently labelled small-molecule inhibitor of Sirt2. This is used in a binding assay, which is based on fluorescence polarization. We used it successfully to map potential inhibitor-binding sites and also to show cellular Sirt2 engagement. By means of these new assays, we were able to identify and characterize novel Sirt2 inhibitors out of a focused library screen. The binding of the identified Sirt2 inhibitors was rationalized by molecular docking studies. These new chemical tools thus can enhance further sirtuin research.This article is part of a discussion meeting issue 'Frontiers in epigenetic chemical biology'.

摘要

去乙酰化酶是 NAD 依赖性的蛋白去酰基酶,能够从组蛋白和其他底物蛋白的赖氨酸 ε-氨基上切割掉乙酰基以及其他酰基。它们已被报道为很有前途的药物靶点,因此需要它们的活性调节剂作为分子工具来揭示它们的生物学功能和作为潜在的治疗方法。在这里,我们提出了新的测定格式,补充了现有的去乙酰化酶生物化学和细胞靶标结合的测定。首先,我们报告了使用未标记的酰化肽开发的均相荧光活性测定法。去酰化后,游离赖氨酸残基与荧光胺反应形成荧光团。其次,我们使用点击化学和炔丙基化的 Sirt2 抑制剂上的 TAMRA-叠氮化物,制备了第一个荧光标记的 Sirt2 小分子抑制剂。该抑制剂用于基于荧光偏振的结合测定。我们成功地使用它来绘制潜在抑制剂结合位点,并显示细胞 Sirt2 结合。通过这些新的测定方法,我们能够从聚焦文库筛选中鉴定和表征新型 Sirt2 抑制剂。通过分子对接研究来合理化鉴定的 Sirt2 抑制剂的结合。这些新的化学工具因此可以增强进一步的去乙酰化酶研究。本文是“表观遗传化学生物学前沿”讨论会议的一部分。